A detailed history of Whittier Trust CO Of Nevada Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 85,975 shares of BMY stock, worth $4.96 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
85,975
Previous 91,660 6.2%
Holding current value
$4.96 Million
Previous $3.81 Million 16.89%
% of portfolio
0.12%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$39.66 - $51.75 $225,467 - $294,198
-5,685 Reduced 6.2%
85,975 $4.45 Million
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $79,856 - $105,132
1,984 Added 2.21%
91,660 $3.81 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $97,399 - $110,432
-2,030 Reduced 2.21%
89,676 $4.86 Million
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $129,247 - $154,228
-2,666 Reduced 2.82%
91,706 $4.71 Million
Q3 2023

Oct 27, 2023

SELL
$57.89 - $64.73 $213,845 - $239,112
-3,694 Reduced 3.77%
94,372 $5.48 Million
Q2 2023

Jul 24, 2023

BUY
$63.71 - $70.74 $72,056 - $80,006
1,131 Added 1.17%
98,066 $6.27 Million
Q1 2023

Apr 21, 2023

SELL
$65.71 - $74.53 $120,249 - $136,389
-1,830 Reduced 1.85%
96,935 $6.72 Million
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $17,599 - $20,840
-257 Reduced 0.26%
98,765 $0
Q3 2022

Oct 21, 2022

SELL
$0.13 - $76.84 $117 - $69,232
-901 Reduced 0.9%
99,022 $7.04 Million
Q2 2022

Jul 28, 2022

SELL
$72.62 - $79.98 $111,544 - $122,849
-1,536 Reduced 1.51%
99,923 $7.69 Million
Q1 2022

Apr 29, 2022

BUY
$61.48 - $73.72 $48,876 - $58,607
795 Added 0.79%
101,459 $7.41 Million
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $338,351 - $394,438
-6,309 Reduced 5.9%
100,664 $6.28 Million
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $52,424 - $61,408
-886 Reduced 0.82%
106,973 $6.33 Million
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $30,150 - $32,833
-487 Reduced 0.45%
107,859 $7.21 Million
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $48,006 - $53,992
809 Added 0.75%
108,346 $6.84 Million
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $102,373 - $116,007
-1,773 Reduced 1.62%
107,537 $6.67 Million
Q3 2020

Oct 30, 2020

SELL
$57.43 - $63.64 $11,773 - $13,046
-205 Reduced 0.19%
109,310 $6.59 Million
Q2 2020

Jul 10, 2020

SELL
$54.82 - $64.09 $781,239 - $913,346
-14,251 Reduced 11.51%
109,515 $6.44 Million
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $324,104 - $470,998
-6,985 Reduced 5.34%
123,766 $6.9 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $785,785 - $1.02 Million
15,968 Added 13.91%
130,751 $8.39 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $64,967 - $77,028
-1,519 Reduced 1.31%
114,783 $5.82 Million
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $330,723 - $365,708
-7,412 Reduced 5.99%
116,302 $5.27 Million
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $40,698 - $48,527
-902 Reduced 0.72%
123,714 $5.9 Million
Q4 2018

Feb 07, 2019

SELL
$48.76 - $63.23 $722,428 - $936,815
-14,816 Reduced 10.63%
124,616 $6.48 Million
Q3 2018

Oct 23, 2018

SELL
$55.19 - $62.25 $46,745 - $52,725
-847 Reduced 0.6%
139,432 $8.66 Million
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $1.5 Million - $1.86 Million
29,601 Added 26.75%
140,279 $7.76 Million
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $1.39 Million - $1.73 Million
-27,548 Reduced 19.93%
110,678 $5.37 Million
Q1 2018

May 01, 2018

BUY
$59.92 - $68.98 $461,204 - $530,939
7,697 Added 5.9%
138,226 $8.74 Million
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $432,407 - $471,434
7,214 Added 5.85%
130,529 $8 Million
Q3 2017

Oct 23, 2017

BUY
$55.23 - $63.74 $6.81 Million - $7.86 Million
123,315
123,315 $7.86 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.